With the potential to not only support weight loss but also improve long-term metabolic health, GLP-1s offer powerful tools for those struggling with obesity, type 2 diabetes, and other metabolic conditions
The Molecular Targets Driving the Revolution Modern incretin-based therapies harness three key hormone receptors that work together to regulate glucose metabolism, appetite, and energy balance: GLP-1R (Glucagon-Like Peptide-1 Receptor) Activated by drugs such as Semaglutide , this receptor stimulates insulin secretion, slows gastric emptying, and promotes satiety, helping reduce food intake and improve blood glucose control
We know that weight loss can be a long and challenging journey, but with Zepbound, you may be able to achieve your weight loss goals more effectively
Commercial patch safety concerns Without clinical trials or regulatory oversight, the safety profile of commercial patches is largely unknown: Ingredient quality : No verification of purity or potency Skin reactions : Adhesives and ingredients may cause irritation or allergic responses Interactions : Herbal components like berberine may interact with medications Undisclosed ingredients : Some patches may contain undeclared substances The MHRA doesnt evaluate these products before they reach the market, and adverse events arent systematically collected or reviewed
Our DMPK team combines fast, unbiased LC-HRMS platform, in vitro testing, and biotransformation study services to assess metabolic stability, capture the full picture of how peptides are metabolized, and provide actionable insights for peptide candidates